Lead sponsor
Sun Yat-sen University
5 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
5
Trials led
2
Active
1,183
Total enrollment
26
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 3
2
Phase 4
2
Not applicable
1
Trials by status
Not yet recruiting
2
Completed
2
Unknown
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic PatientsBMI ≤10not applicableCompleted416